Frederick M. Wigley

Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy

Olga Y. Gorlova, Jose‐Ezequiel Martín, Jose‐Ezequiel Martín et al. · PLoS Genetics · 2011 · 233 citations · Full text

Life Sciences, Genetics, Immunology +17

Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products

Kane L. Schaphorst, Eddie T. Chiang, KERI JACOBS et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2003 · 179 citations

Life Sciences, Cell Biology, Physiology +13

Insulin Across Respiratory Mucosae by Aerosol Delivery

Frederick M. Wigley, Javier H. Londono, Scott H Wood et al. · Diabetes · 1971 · 175 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

A multicenter, randomized, double‐blind, placebo‐controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. Oral type I collagen does not improve skin in all patients, but may improve skin in late‐phase disease

Arnold E. Postlethwaite, Weng Kee Wong, Philip J. Clements et al. · Arthritis & Rheumatism · 2008 · 114 citations · Full text

Medicine, Clinical Sciences, Dermatology +14

Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS)

Kathleen D. Kolstad, Shufeng Li, Virginia Steen et al. · CHEST Journal · 2018 · 104 citations · Full text

Medicine, Cardiology, Clinical Sciences +8